July Newsmakers

Glioblastoma: New tools against brain cancer (CBS News)
Features Henry Friedman, MD
'Glioblastoma is grisly': How brain cancer affected my family (WUSA-9)
Features Henry Friedman, MD
Duke neurosurgeon: Many factors in McCain's favor as he undergoes cancer treatment (WRAL)
Features Peter Fecci, MD, PhD
Duke is expert at fighting tumor facing John McCain (WNCN)
Features Peter Fecci, MD, PhD
Duke University Medical Center leads fight against McCain's form of cancer (WTVD)
Features Peter Fecci, MD, PhD
F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment (The New York Times)
Features Duke leukemia patient
His father died from prostate cancer. Now he’s helping Duke find a possible cure (Durham Herald Sun)
Features Daniel George, MD
Duke researchers advance potential treatment for leukemia (The Chronicle)
Features Edward F. Patz, Jr., MD
A Mosaic: The Many Faces of Cancer (Medium)
Features Duke photographer Jared Lazarus and Duke Cancer Center patients
Mobile app developed at Duke helping survivors battle 'cancer PTSD' (WRAL)
Features Sophia Smith, PhD, MSW
Cancer survivor? Duke’s new PTSD app helps patients and families overcome trauma of diagnosis and treatment (Durham Herald Sun)
Features Sophia Smith, PhD, MSW
In Depth: Duke's Nolan Smith tackling teen cancer (Time Warner Cable News)
Nolan Smith, fellow basketball stars want to ‘coach’ you while raising money for cancer (Durham Herald Sun)
Human antibody bolsters cancer drug performance (Medical News Today)
Features Edward F. Patz, Jr., MD
Antiquated' Medullary Thyroid Cancer Staging Gets Update (Medscape)
Features Julie Sosa, MD
CDK4/CDK6 Inhibitors Show Promise in Advanced Postmenopausal Breast Cancer (The Oncology Nurse)
Features Linda M. Sutton, MD, and Susan Kane, BSN, RN, CBCN
Risk-reducing mastectomy questioned for BRCA mutation carriers with prior ovarian cancer (Science Daily)
Features Charlotte Gamble, MD and Rachel Greenup, MD
Duke Launches Project Baseline Study Enrollment in North Carolina (Duke SOM)
Features P. Kelly Marcom, MD
WATCH: Dr. Marcom on the FDA Approval of Ribociclib in HR+ Breast Cancer (OncLive)
Features P. Kelly Marcom, MD
WATCH: Endocrine Resistance in HR+ Metastatic Breast Cancer (OncLive)
Features Kimberly Blackwell, MD
Bone scan index reliably predicts prostate cancer outcomes (Healio)
Features Andrew Armstrong, MD
Biscuits, breweries combine for ultimate showdown (The News & Observer)
Duke Cancer Institute’s Give 1 For Dad campaign to benefit prostate cancer research
Big Biscuit Showdown menu includes adventurous combinations (WRAL)
Duke Cancer Institute’s Give 1 For Dad campaign to benefit prostate cancer research
PAPERS:
Christopher D. Kassotis, PhD (Duke University Nicholas School for the Environment), Kate Hoffman, PhD, MSES, MPA (Duke University Nicholas School for the Environment), Heather M. Stapleton, PhD (Duke University Nicholas School for the Environment, Member of Duke Cancer Institute). Characterization of Adipogenic Activity of House Dust Extracts and Semi-Volatile Indoor Contaminants in 3T3-L1 Cells. Environmental Science & Technology, 2017; DOI: 10.1021/acs.est.7b01788 (With funding from Duke Cancer Institute, Fred and Alice Stanback and the National Institute of Environmental Health Sciences)